Market Re-forecasts: Health and Wellbeing - US - April 2009

Table of Contents

• Introduction: Reforecasting Puts Markets in Fresh Light
• Intelligent planning brings opportunities
• Fresh insight for making smart decisions
• Cigarettes and Smoking Cessation Aids
• Key points
• Cessation aid market size and forecast January 12, 2009
  • Figure 1: Total U.S. sales of cessation aids, at current prices, 2003-13
  • Figure 2: Total U.S. sales of cessation aids, at inflation-adjusted prices, 2003-13
• Cigarette and tobacco products size and forecast -- January 12, 2009
  • Figure 3: Total U.S. sales and forecast of cigarettes and tobacco products, at current prices, 2003-13
  • Figure 4: Total U.S. sales and forecast of cigarettes and tobacco products, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published March 2008
  • Figure 5: Total U.S. sales and forecast of cigarettes and tobacco products, at current prices, 2003-11
  • Figure 6: Total U.S. sales and forecast of cigarettes and tobacco products, at constant prices, 2003-11
  • Figure 7: U.S. FDMx sales and forecast of smoking cessation products, at current prices, 2003-11
  • Figure 8: U.S. FDMx sales and forecast of smoking cessation products, at current prices and constant prices, 2003-11
  • Figure 9: U.S. FDMx sales and forecast of smoking cessation products, at current prices, 2003-11
  • Figure 10: U.S. FDMx sales and forecast of smoking cessation products, at current prices and constant prices, 2003-11
• Cold, Flu and Allergy Remedies
• Key points
• Market size and forecast - January 12, 2009
  • Figure 11: Total U.S. retail sales of cold, flu, and allergy remedies, at current prices, 2003-13
  • Figure 12: Total U.S. retail sales of cold, flu, and allergy remedies, at inflation-adjusted prices, 2003-13
• Tablets
  • Figure 13: Total U.S. retail sales of cold, flu, and allergy tablets, at current prices, 2003-13
• Liquids
  • Figure 14: Total U.S. retail sales of cold, flu, and allergy liquids, at current prices, 2003-13
• Nasal products
  • Figure 15: Total U.S. retail sales of cold, flu, and allergy nasal products, at current prices, 2003-13
• Market size and forecast originally published October 2007
  • Figure 16: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
  • Figure 17: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12
  • Figure 18: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07
  • Figure 19: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12
  • Figure 20: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07
  • Figure 21: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12
  • Figure 22: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07
  • Figure 23: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12
• Contraceptives
• Key points
• Market size and forecast -- January 12, 2009
  • Figure 24: OTC (FDMx and convenience store) sales and forecast of contraceptives, at current prices, 2003-13
  • Figure 25: OTC (FDMx and convenience store) sales and forecast of contraceptives, at inflation-adjusted prices, 2003-13
  • Figure 26: Condom market size and forecast, at current prices, 2003-13
  • Figure 27: Condom market size and forecast, at inflation-adjusted prices, 2003-13
  • Figure 28: Female condoms, spermicidal, and Plan B, at current prices, 2003-13
  • Figure 29: Female condoms, spermicidal, and Plan B at inflation-adjusted prices, 2003-13
  • Figure 30: Lubricants and enhancements sales and forecast, at current prices, 2003-13
  • Figure 31: Lubricants and enhancements sales and forecast, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published from June 2008
  • Figure 32: OTC (FDMx and convenience store) sales and forecast of contraceptives, at current prices, 2002-12
  • Figure 33: OTC (FDMx and convenience store) sales and forecast of contraceptives, at inflation adjusted prices, 2002-12
  • Figure 34: U.S. sales and forecast of condoms at FDMx and C-stores, at current prices, 2002-12
  • Figure 35: U.S. sales and forecast of condoms at FDMx and C-stores, at inflation-adjusted prices, 2002-12
  • Figure 36: U.S. sales and forecast of lubrication and enhancement products, at current prices, 2002-12
  • Figure 37: U.S. sales and forecast of lubrication and enhancement products, at inflation-adjusted products, 2002-12
• Cough and Throat Remedies
• Key points
• Market size and forecast - January 29, 2009
  • Figure 38: FDMx and c-store sales and forecast of cough and throat remedies, at current prices, 2003-13
  • Figure 39: FDMx and c-store sales and forecast of cough and throat remedies, at inflation-adjusted prices, 2003-13
  • Figure 40: FDMx and c-store sales and forecast of cough drops, at current prices, 2003-13
  • Figure 41: FDMx and c-store sales and forecast of cough syrups, at current prices, 2003-13
  • Figure 42: FDMx and c-store sales and forecast of sore throat liquids, at current prices 2003-13
• Market size and forecast originally published from May 2008
  • Figure 43: Total FDMx and c-store sales and forecast of cough and throat remedies, at current prices, 2002-12
  • Figure 44: Total FDMx and c-store sales and forecast of cough and throat remedies, at inflation-adjusted prices, 2002-12
  • Figure 45: U.S. FDMx sales and forecast of cough drops, at current prices, 2002-12
  • Figure 46: U.S. FDMx sales and forecast of cough syrups, at current prices, 2002-12
  • Figure 47: U.S. FDMx sales and forecast of sore throat liquids, at current prices, 2002-12
• First Aid
• Key points
• Market size and forecast -- January 12, 2009
  • Figure 48: U.S. FDMx sales of first aid accessories and treatment, at current prices, 2003-13
  • Figure 49: U.S. FDMx sales of first aid accessories and treatment, at inflation-adjusted prices, 2003-13
  • Figure 50: U.S. FDMx sales and forecast of first aid accessories*, at current prices, 2003-13
  • Figure 51: U.S. FDMx sales and forecast of first aid treatments*, at current prices, 2003-13
• Market size and forecast originally published July 2008
  • Figure 52: U.S. FDMx sales of first aid accessories and treatment, at current prices, 2002-12
  • Figure 53: U.S. FDMx sales of first aid accessories and treatment, at inflation adjusted prices, 2002-12
  • Figure 54: U.S. FDMx sales and forecast of first aid accessories*, at current prices, 2002-12
  • Figure 55: U.S. FDMx sales and forecast of first aid treatments*, at current prices, 2002-12
• Functional Beverages
• Key points
  • Figure 56: FDMx sales and forecast of functional beverages, at current prices, 2003-13
  • Figure 57: FDMx sales and forecast of functional beverages, at inflation-adjusted prices, 2003-13
  • Figure 58: FDMx sales and forecast of functional juice and juice drinks, at current prices, 2003-13
  • Figure 59: U.S. FDMx sales and forecast of enhanced water, at current prices, 2003-13
  • Figure 60: FDMx sales and forecast of energy drinks, at current prices, 2003-13
  • Figure 61: FDMx sales and forecast of functional tea, at current prices, 2003-11
  • Figure 62: FDMx sales and forecast of functional yogurt drinks and smoothies, at current prices, 2003-11
  • Figure 63: U.S. FDMx sales and forecast of functional soy-, almond- and rice-based drinks, at current prices, 2003-11
• Market size and forecast originally published from August 2008
  • Figure 64: FDMx sales and forecast of functional beverages, at current prices, 2003-11
  • Figure 65: FDMx sales and forecast of functional beverages, at inflation-adjusted prices, 2003-11
  • Figure 66: FDMx sales and forecast of functional juice and juice drinks, at current prices, 2003-11
  • Figure 67: U.S. FDMx sales and forecast of enhanced water, at current prices, 2003-11
  • Figure 68: FDMx sales and forecast of energy drinks, at current prices, 2003-11
  • Figure 69: FDMx sales and forecast of functional tea, at current prices, 2003-11
  • Figure 70: FDMx sales and forecast of functional yogurt drinks and smoothies, at current prices, 2003-11
  • Figure 71: U.S. FDMx sales and forecast of functional soy-, almond- and rice-based drinks, at current prices, 2003-11
• Gastrointestinal Remedies
• Key points
• Market size and forecast - January 12, 2009
  • Figure 72: Total U.S. sales and forecast of gastrointestinal remedies, at current prices, 2003-13
  • Figure 73: Total U.S. sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2003-13
  • Figure 74: FDMx sales and forecast of antacids, at current prices, 2003-13
  • Figure 75: FDMx sales and forecast of antacids, at inflation-adjusted prices, 2003-13
  • Figure 76: U FDMx sales and forecast of laxatives, at current prices, 2003-13
  • Figure 77: FDMx sales and forecast of laxatives, at inflation-adjusted prices, 2003-13
  • Figure 78: FDMx sales and forecast of anti-diarrheals, at current prices, 2003-13
  • Figure 79: FDMx sales and forecast of anti-diarrheals, at inflation-adjusted prices, 2003-13
  • Figure 80: FDMx sales and forecast of stomach remedies, at current prices, 2003-13
  • Figure 81: FDMx sales and forecast of stomach remedies, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published September 2008
  • Figure 83: Total U.S. sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2003-13
  • Figure 84: FDMx sales and forecast of antacids, 2003-13*
  • Figure 85: FDMx sales and forecast of laxatives, 2003-13
  • Figure 86: FDMx sales and forecast of anti-diarrheals, 2003-13
  • Figure 87: FDMx sales and forecast of stomach remedies, 2003-13
• Glasses and Contact Lenses
• Key points
• Market size and forecast -- January 12, 2009
  • Figure 88: Total U.S. sales and forecast of glasses and contact lenses, at current prices, 2003-13
  • Figure 89: Total U.S. sales and forecast of glasses and contact lenses, at inflation-adjusted prices*, 2003-13
• Market size and forecast originally published from April 2008
  • Figure 90: Total U.S. sales and forecast of glasses and contact lenses, at current prices, 2002-12
  • Figure 91: Total U.S. sales and forecast of glasses and contact lenses, at inflation-adjusted prices*, 2002-12
  • Figure 92: Total U.S. sales and forecast of prescription eyeglasses, at current prices, 2002-12
  • Figure 93: Total U.S. sales and forecast of prescription eyeglasses, at inflation-adjusted prices*, 2002-12
  • Figure 94: Total U.S. sales and forecast of contact lenses, at current prices, 2002-12
  • Figure 95: Total U.S. sales and forecast of contact lenses, at inflation-adjusted prices*, 2002-12
  • Figure 96: Total U.S. sales and forecast of off-the-shelf glasses and sunglasses, at current prices, 2002-12
  • Figure 97: Total U.S. sales and forecast of off-the-shelf glasses and sunglasses, at inflation-adjusted prices*, 2002-12
  • Figure 98: Total U.S. sales and forecast of contact lens care products, at current prices, 2002-12
  • Figure 99: Total U.S. sales of contact lens care products, at inflation-adjusted prices*, 2002-12
  • Figure 100: Total U.S. sales and forecast of all other optical goods and accessories, at current prices, 2002-12
  • Figure 101: Total U.S. sales and forecast of all other optical goods and accessories, at inflation-adjusted prices*, 2002-12
• Hair Loss Remedies
• Key points
• Market size and forecast originally published December 2008
  • Figure 102: U.S. sales of hair loss remedies, at current prices, 2003-11
  • Figure 103: U.S. sales of hair loss remedies, at inflation-adjusted prices, 2003-11
  • Figure 104: U.S. sales and forecast of prescription hair loss remedies, 2003-11
  • Figure 105: FDMx sales of OTC hair loss remedies, 2003-11
• Health and Fitness Clubs
• Key points
• Market size and forecast - January 12, 2009
  • Figure 106: Health and fitness clubs total revenues, at current prices, 2003-13
  • Figure 107: Health and fitness clubs total revenues, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published June 2008
  • Figure 108: Health and fitness clubs total revenues, at current prices, 2002-12
• Figure 109: Health and fitness clubs total revenues, at inflation adjusted prices, 2002-12
• Nuts and Dried Fruit
• Key points
• Market size and forecast, March 2009
  • Figure 110: Total U.S. sales and forecast of nuts and dried fruit through all channels, at current prices, 2003-13
  • Figure 111: Total U.S. sales and forecast of nuts and dried fruit through all channels, at inflation adjusted prices, 2003-13
• Segment sales and forecast March 2009
  • Figure 112: Sales of snack nuts and seeds, 2003-13
  • Figure 113: Sales of dried fruit, 2003-13
  • Figure 114: Sales of baking nuts, 2003-13
  • Figure 115: Sales of trail mix, 2003-13
• Market size and forecast originally published from July 2007
  • Figure 116: U.S. retail sales of nuts and dried fruit through all channels, at current and constant prices, 2001-06
  • Figure 117: Forecast of total U.S. retail sales of nuts and dried fruit through all channels, at current and constant prices, 2007-12
• Oral Care
• Key points
• Market size and forecast -- January 31, 2009
  • Figure 118: U.S. FDMx sales and forecast of oral care and dental hygiene products, at current prices, 2003-13
  • Figure 119: U.S. FDMx sales and forecast of oral care and dental hygiene products, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published June 2008
  • Figure 120: U.S. FDMx sales and forecast of oral care and dental hygiene products, at current prices, 2002-12
  • Figure 121: U.S. FDMx sales and forecast of oral care and dental hygiene products, at inflation-adjusted prices, 2002-12
• Organic Beverages
• Key points
• Market size and forecast - January 12, 2009
  • Figure 122: Total U.S. sales and forecast of organic beverages, at current prices, 2003-13
  • Figure 123: Total U.S. sales and forecast of organic beverages, at inflation-adjusted prices, 2003-13
  • Figure 124: U.S. sales and forecast of non-dairy beverages, at current prices, 2003-13
  • Figure 125: U.S. sales and forecast organic dairy beverages, at current prices, 2003-13
• Market size and forecast originally published from September 2008
  • Figure 126: Total U.S. sales and forecast of organic beverages, at current prices, 2003-13
  • Figure 127: Total U.S. sales and forecast of organic beverages, at inflation-adjusted prices, 2003-13
  • Figure 128: U.S. sales and forecast of non-dairy beverages, at current prices, 2003-13
  • Figure 129: U.S. sales and forecast organic dairy beverages, at current prices, 2003-13
• Organic Food
• Key points
• Market size and forecast - January 12, 2009
  • Figure 130: Total U.S. sales and forecast of organic food, at current prices, 2003-13
  • Figure 131: Total U.S. sales and forecast of organic food, at inflation adjusted prices, 2003-13
  • Figure 132: U.S. sales and forecast of organic prepared and packaged food, at current prices, 2003-13
  • Figure 133: U.S. sales and forecast of organic fruit and vegetables, at current prices, 2003-13
  • Figure 134: U.S. sales and forecast of organic snacks, at current prices, 2003-13
  • Figure 135: U.S. sales and forecast of organic grain products, at current prices, 2003-13
  • Figure 136: U.S. sales and forecast of organic dairy products, at current prices, 2003-13
  • Figure 137: U.S. sales and forecast of organic meat, at current prices, 2003-13
  • Figure 138: U.S. sales and forecast of other organic food, at current prices, 2003-13
• Market size and forecast originally published October 2008
  • Figure 139: Total U.S. sales and forecast of organic food at current prices, at current prices, 2003-13
  • Figure 140: Total U.S. sales and forecast of organic food, at inflation adjusted prices, 2003-13
  • Figure 141: U.S. sales and forecast of organic prepared and packaged food, at current prices, 2003-13
  • Figure 142: U.S. sales and forecast of organic fruit and vegetables, at current prices, 2003-13
  • Figure 143: U.S. sales and forecast of organic snacks, at current prices, 2003-13
  • Figure 144: U.S. sales and forecast of organic grain products, at current prices, 2003-13
  • Figure 145: U.S. sales and forecast of organic dairy products, at current prices, 2003-13
  • Figure 146: U.S. sales and forecast of organic meat, at current prices, 2003-13
  • Figure 147: U.S. sales and forecast of other organic food, at current prices, 2003-13
• OTC Analgesics
• Key points
• Market size and forecast -- January 12, 2009
  • Figure 148: Total U.S. retail sales of OTC internal analgesics, at current prices, 2003-13
  • Figure 149: Total U.S. retail sales of OTC internal analgesics, at inflation-adjusted prices, 2003-13
  • Figure 150: FDM sales of OTC analgesic tablets, at current prices, 2003-13
  • Figure 151: FDM sales of OTC analgesic tablets, at inflation-adjusted prices, 2003-13
  • Figure 152: FDM sales of OTC analgesic liquids, at current prices, 2003-13
  • Figure 153: FDM sales of OTC analgesic liquids, at inflation-adjusted prices, 2003-13
  • Figure 154: FDM sales of OTC feminine pain relievers, at current prices, 2003-13
  • Figure 155: FDM sales of OTC feminine pain relievers, at inflation-adjusted prices, 2003-13
• Market size and forecast originally published from November 2007
  • Figure 156: Total U.S. retail sales of OTC internal analgesics, at current and constant prices, 2002-07
  • Figure 157: Forecast of total U.S. retail sales of OTC internal analgesics, at current and constant prices, 2007-12
  • Figure 158: FDM sales of private label OTC analgesics, at current and constant prices, 2002-07
  • Figure 159: Forecast of U.S. FDM sales of private label OTC analgesics, at current and constant prices, 2007-12
  • Figure 160: FDM sales of OTC analgesic tablets, at current and constant prices, 2002-07
  • Figure 161: Forecast of U.S. FDM sales of OTC analgesic tablets, at current and constant prices, 2007-12
  • Figure 162: FDM sales of OTC analgesic liquids, at current and constant prices, 2002-07
  • Figure 163: Forecast of U.S. FDM sales of OTC analgesic liquids, at current and constant prices, 2007-12
  • Figure 164: FDM sales of OTC feminine pain relievers, at current and constant prices, 2002-07
  • Figure 165: Forecast of U.S. FDM sales of OTC feminine pain relievers, at current and constant prices, 2007-12
• OTC Pediatrics
• Key points
• Market size and forecast, February 2009
  • Figure 166: Total U.S. FDMx sales and forecast of OTC pediatrics at current prices, 2003-13
  • Figure 167: Total U.S. FDMx sales and forecast of OTC pediatrics at inflation adjusted prices, 2003-13
  • Figure 168: U.S. FDMx sales and forecast of pediatric internal analgesics, 2003-13
  • Figure 169: U.S. FDMx sales and forecast of pediatric cold/allergy/sinus remedies, 2003-13
  • Figure 170: U.S. FDMx sales and forecast of baby formula/electrolytes, 2003-13
  • Figure 171: U.S. FDMx sales and forecast of pediatric vitamins, 2003-13
  • Figure 172: U.S. FDMx sales and forecast of pediatric nasal products, 2003-13
  • Figure 173: U.S. FDMx sales and forecast of pediatric GI remedies, 2003-13
  • Figure 174: U.S. FDMx sales and forecast of pediatric cough remedies, 2003-13
  • Figure 175: U.S. FDMx sales and forecast of miscellaneous pediatric health remedies, 2003-13
• Market size and forecast originally published October 2008
  • Figure 176: Total U.S. FDMx sales and forecast of OTC pediatrics at current prices, 2003-13
  • Figure 177: Total U.S. FDMx sales and forecast of OTC pediatrics at inflation adjusted prices, 2003-13
  • Figure 178: U.S. FDMx sales and forecast of pediatric internal analgesics, 2003-13
  • Figure 179: U.S. FDMx sales and forecast of pediatric cold/allergy/sinus remedies, 2003-13
  • Figure 180: U.S. FDMx sales and forecast of baby formula/electrolytes, 2003-13
  • Figure 181: U.S. FDMx sales and forecast of pediatric vitamins, 2003-13
  • Figure 182: U.S. FDMx sales and forecast of pediatric nasal products, 2003-13
  • Figure 183: U.S. FDMx sales and forecast of pediatric GI remedies, 2003-13
  • Figure 184: U.S. FDMx sales and forecast of pediatric cough remedies, 2003-13
  • Figure 185: U.S. FDMx sales and forecast of miscellaneous pediatric health remedies, 2003-13
• Self Diagnostics
• Key points
• Market size and forecast - January 29, 2009
  • Figure 186: Total FDMx sales and forecast of self diagnostics, at current prices, 2003-13
  • Figure 187: Total FDMx sales and forecast of self diagnostics, at inflation-adjusted prices, 2003-13
  • Figure 188: Total FDMx sales and forecast of glucose monitors, at current prices, 2003-13
  • Figure 189: Total FDMx sales and forecast of pregnancy tests, at current prices, 2003-13
  • Figure 190: Total FDMx sales and forecast of blood pressure monitors, at current prices, 2003-13
  • Figure 191: Total FDMx sales and forecast of ovulation tests, 2003-13
• Market size and forecast originally published from January 2008
  • Figure 192: Total FDMx sales and forecast of self diagnostics, at current prices, 2002-12
  • Figure 193: Total FDMx sales and forecast of self diagnostics, at inflation-adjusted prices, 2002-12
  • Figure 194: Total FDMx sales and forecast of glucose monitors, at current prices, 2002-12
  • Figure 195: Total FDMx sales and forecast of pregnancy tests, at current prices, 2002-12
  • Figure 196: Total FDMx sales and forecast of blood pressure monitors, at current prices, 2002-12
  • Figure 197: Total FDMx sales and forecast of ovulation tests, at current prices, 2002-12
• Slimming Meals
• Key points
• Market size and forecast March, 2009
  • Figure 198: U.S. sales of slimming meals, at current prices, 2003-13
  • Figure 199: U.S. sales of slimming meals, at inflation-adjusted prices, 2003-13
  • Figure 200: FDMx sales of frozen slimming meals, at current prices, 2003-13
  • Figure 201: FDMx sales of meal replacement drinks, at current prices, 2003-13
  • Figure 202: FDMx sales of sports and energy bars, at current prices, 2003-13
• Market size and forecast originally published January 2007
  • Figure 203: U.S. sales of slimming meals, at current and constant prices, 2001-06
  • Figure 204: Forecast of total U.S. sales of slimming meals, at current and constant prices, 2006-11
  • Figure 8: FDM sales of frozen slimming meals, at current and constant prices, 2001-06
  • Figure 205: Forecast of U.S. FDM sales of frozen slimming meals, at current and constant prices, 2006-11
  • Figure 206: FDM sales of meal replacement drinks, at current and constant prices, 2001-06
  • Figure 207: Forecast of U.S. FDM sales of meal replacement drinks, at current and constant prices, 2006-11
  • Figure 208: FDM sales of sports and energy bars, at current and constant prices, 2001-06
  • Figure 209: Forecast of U.S. FDM sales of sports and energy bars, at current and constant prices, 2006-11
• Sugar-Free Foods and Beverages
• Key points
• Market size and forecast, February 2009
  • Figure 210: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current prices, 2003-13
  • Figure 211: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at inflation-adjusted prices, 2003-13
  • Figure 212: FDMx sales of sugar-free soft drinks/soda, at current prices, 2005-11
  • Figure 213: FDMx sales of sugar-free gum, at current prices, 2005-11
  • Figure 214: FDMx sales of sugar-free chocolate confectionery, at current prices, 2005-11
  • Figure 215: FDMx sales of sugar-free non-chocolate confectionery, at current prices, 2005-11
• Market size and forecast originally published June 2007
  • Figure 216: U.S. sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current and constant prices, 2001-06
  • Figure 217: Forecast of total U.S. retail sales of sugar-free gum, chocolate confectionery, non-chocolate confectionery, and carbonated beverages, at current and constant prices, 2006-11
  • Figure 218: FDM sales of sugar-free soft drinks/soda, at current and constant prices, 2001-06
  • Figure 219: Forecast of U.S. FDM sales of sugar-free soft drinks/soda, at current and constant prices, 2006-11
  • Figure 220: FDM sales of sugar-free gum, at current and constant prices, 2001-06
  • Figure 221: Forecast of U.S. FDM sales of sugar-free gum, at current and constant prices, 2006-11
  • Figure 222: FDM sales of sugar-free chocolate confectionery, at current and constant prices, 2001-06
  • Figure 223: FDM sales of sugar-free non-chocolate confectionery, at current and constant prices, 2001-06
• Vitamins and Minerals
• Key points
• Market size and forecast -- January 29, 2009
  • Figure 224: Total FDMx sales and forecast of vitamins and minerals, at current prices, 2003-13
  • Figure 225: Total FDMx sales and forecast of vitamins and minerals, at inflation-adjusted prices, 2003-13
  • Figure 226: Total FDMx sales and forecast of mineral supplements, at current prices, 2003-13
  • Figure 227: Total FDMx sales and forecast of multi-vitamins, at current prices, 2003-13
  • Figure 228: Total FDMx sales and forecast of 1 & 2 letter vitamins, at current prices, 2003-13
  • Figure 229: Total FDMx sales and forecast of liquid vitamins and minerals, at current prices 2003-13
• Market size and forecast originally published from September 2007
  • Figure 230: Total FDMx sales and forecast of vitamins and minerals, at current prices, 2002-12
  • Figure 231: Total FDMx sales and forecast of vitamins and minerals, at inflation-adjusted prices, 2002-12
  • Figure 232: Total FDMx sales and forecast of mineral supplements, at current prices, 2002-12
  • Figure 233: Total FDMx sales and forecast of multi-vitamins, at current prices, 2002-12
  • Figure 234: Total FDMx sales and forecast of 1 & 2 letter vitamins, at current prices, 2002-12
  • Figure 235: Total FDMx sales and forecast of liquid vitamins and minerals, at current prices, 2002-12